Skip to main content
  • ENG
  • FR

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV-supported projects
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for discovery scientists
    • Project of the year award
    • Computational chemistry
      • Global health compound design webinars
    • R&D challenges
  • Access
    • Products & projects
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Product maps
    • Tool Kits
      • Injectable Artesunate tool kit
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • The road to health impact
    • Access challenges
  • Partnering
    • Our partner network
    • The PDP model
    • Socially responsible agreements
    • Our clinical centre partners
    • Our donors
      • Current donors
      • Past donors
      • Donate to MMV
  • Our impact
    • Achievements
    • Real life stories
    • Better medicines for children
    • Malaria and COVID-19
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff map
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
      • MMV's internship programme
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • Five species
    • Parasite lifecycle
    • Malaria facts & figures
    • Malaria treatment
    • History of antimalarials
    • Optimizing artemisinin production
    • Malaria online course
  • Newsroom
    • News & Press Releases
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Audio
    • Events
  • MMV Open
    • Malaria Libre
      • About Malaria Libre
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • COVID Box
      • About the COVID Box
      • Request the COVID box
      • Supporting information
      • COVID Box terms and conditions
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • Pathogen Box
      • About the Pathogen Box
      • Exploiting the Pathogen Box
      • Pathogen Box research
      • Supporting information
      • Terms & conditions
    • Malaria Box
      • About the Malaria Box
      • Malaria Box Research
      • Supporting information
      • Terms & conditions
    • Map of box orders
    • Follow-up guidelines
    • Open Source Drug Discovery
    • MMV Open Team
    • Contact us
  • Our 19th Call for Proposals is now open!

  • Discover a slideshow on combatting antimicrobial resistance

    Photo: Novartis
  • Read the story of Chola, a Community Facilitator, in the context of COVID-19

    Photo: Toby Madden/Transaid

Achievements

  • .
    150
    active partners

    working to help defeat malaria – part of an overall network of 400 partners in 50 countries

  • .
    168m
    vials

    of injectable artesunate for severe malaria delivered since 2010, saving the lives of over 1m additional vulnerable children compared with quinine treatment

  • .
    319
    Pathogen Boxes

    shipped free of charge to scientists around the world to boost drug discovery for neglected diseases

Home

News

Pioneer in clinical pharmacology will be deeply missed 

MMV mourns the loss of Professor Sir Colin Dollery

29 Jan 2021
News story

PDPs reduce investment risks and stretch limited budgets leading to 375 innovations targeting infectious diseases under development. 

New report demonstrates how R&D partnerships serving neglected communities have developed dozens of life-saving innovations since 2010

28 Jan 2021
Press release

SMC IMPACT aims to expand use of seasonal malaria chemoprevention in five African countries. 

Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel

28 Jan 2021
News story

Acceptance to review the paediatric dossier by the Australian drug regulator is an important and big step towards making this medicine available to the children that need it

GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

08 Jan 2021
Press release
View all news

Defeating malaria together

  • Discover MMV's image slideshows

  • Films and animations

  • Open source research

Featured resources

  • Malaria and COVID-19

    Learn about MMV's activities in the context of COVID-19. 

    Dec 2020
  • Q&A: Scaling up preventive malaria treatment in pregnancy

    Discover how enhancing African manufacturing capacity can increase IPTp coverage in this Q&A in French and English.

    Nov 2020
    Publication
  • MiMBa: Combatting malaria in pregnant and breastfeeding women

    Read more about MMV's initiative to combat malaria in women who are of reproductive potential, pregnant or breastfeeding. 

    Sep 2020
    Publication

Events

There are currently no upcoming events.

View past events
  • RSS subscribe
    Printer friendly

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2021
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap